Business Wire

SmartStream’s Centre of Excellence used by over 20 financial institutions globally and with implementation costs reduced by 65 percent

Del

SmartStream, the financial Transaction Lifecycle Management (TLM®) specialist, today announce over 20 major financial institutions are using their Centre of Excellence (CoE) utilities. The CoE has two distinct services: a Managed Service Utility and a Central On-Boarding Utility (COU) – each aid in the processing of reconciliations, making it faster, more cost-effective and for many firms, lowering the cost of implementation by as much as 65 percent.

In today’s markets, financial institutions need to manage the growing volume of reconciliations which are becoming increasingly complex in nature, making processing more time-consuming and costly. Firms have to overcome this challenge, as well as avoid the rising backlogs. One route financial institutions are exploring is the use of utilities. Working in partnership with a utility vendor allows a financial institution to outsource all or part of the reconciliations handling process, thus enabling them to realise greater savings, faster results and more accurate data.

Since its launch 18 months ago and with over 20 clients now in production, SmartStream has built a deep understanding of the key benefits in using the CoE. Processing has become more efficient and clients have seen an improvement in customer service levels. More specifically, there has been an improvement of match rates in excess of 97 percent and vast increases in STP rates, as well as a reduction in exceptions by as much as 67 percent.

The Central On-Boarding Utility (COU) acts as an off-site delivery arm for a financial institution. SmartStream’s deep domain experience and multiple projects have enabled the COU to see commonalities across processes from which they have built a library of frequently used configurations across different reconciliations. This allows the COU to deploy reconciliations on client sites quicker. A number of clients currently utilising the COU services also have SmartStream’s TLM solutions installed on their own sites.

SmartStream recognises that there is a growing band of financial institutions that wish to access SmartStream’s technology as a utility and there is an increasing desire amongst financial institutions to adopt a fully outsource reconciliations processing service. SmartStream have spent years on creating an offering, which provides access to both its reconciliations processing technology as a utility, and a full end-to-end managed service.

The Managed Service Utility provides reconciliation and exceptions management functionality. It covers the entire, end-to-end reconciliations process, including the hosting of SmartStream’s TLM solutions within the on-demand offering, monitoring the environment, loading data and ensuring auto-matching is completed within agreed SLA’s, as well as performing manual matching and break resolution.

Julian Trostinsky, Managing Director of Central On-Boarding Utility and Managed Services, SmartStream, states: “Since the launch of the utility 18 months ago, we have seen a tremendous surge in demand for its services. Our competitors are only now entering the space. In the mean time we have trained our resources at SmartStream’s CoE to oversee every aspect of the service, therefore reducing the management burden, whilst at the same time ensuring operational excellence. The service also includes risk mitigation, continuous process improvement, scope across business lines and geography, as well as providing clients with access to optimal infrastructure and technology. It is a highly competitive offering, and very unique to other offerings in the market today. In addition, ours is an approach where we place great emphasis on working together in partnership with our customers”.

Looking to the future, SmartStream will be extending the remit of the CoE’s managed service to include not only reconciliations processing but other important solutions, such as TLM Corporate Actions and TLM Cash & Liquidity Management.

Ends

For more information about SmartStream and our solutions visit: www.smartstream-stp.com

Contact information

For further information
Please contact:
Nathan Gee, Senior Marketing Manager, SmartStream
Tel: +44 (0) 20 7898 0630
Email: nathan.gee@smartstream-stp.com
or
Shamira Alidina, Media Relations Director, Dina Communications
Tel +44 (0) 7801 590718
Email: shamira@dinacomms.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease18.7.2018 21:45Pressemelding

VIEW E-MEDIA KIT – Emmaus Life Sciences, Inc. (Emmaus) announced today that the New England Journal of Medicine (NEJM) has published the results of its 48-week phase 3 clinical trial of Endari™ (L-glutamine oral powder) which supported the FDA approval in July 2017 to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older. The article reports results that showed significantly fewer sickle cell crises in those receiving Endari compared to placebo by 25 percent; p=0.005 (median 3 vs. median 4) and significantly fewer hospitalizations by 33 percent; p=0.005 (median 2 vs. median 3). Additional findings showed lower cumulative days in hospital of 41 percent; p=0.02 (median 6.5 days vs. median 11 days) and a lower incidence of acute chest syndrome (ACS) by more than 60 percent; p=0.003 (13 of 152 patients [8.6%] had at least 1 ACS compared with 18 of 78 in the placebo group [23.1%]). The most common adverse reactions, occurring in great

Tigo Releases State-of-the-art Wireless Technology – Mesh – as the New Solar Communication Architecture for the TS4 Platform18.7.2018 19:41Pressemelding

Tigo®, pioneer of the smart modular Flex MLPE platform, today announced the release of its new Mesh communication architecture. This state-of-the-art wireless technology directly translates to customer benefits – including simplifying the solar design process and accelerating the commissioning steps. The complete Tigo solution uses a simple yet powerful data collection technology that covers the widest ranges of residential & commercial installations at the lowest cost. With Mesh and the recently announced Tigo Access Point (TAP), customers eliminate the need to address any roof obstruction or orientation constraint. To learn more about Mesh and TAP, register for Tigo’s free, online webinar “The Future of Solar is Wireless” on Wednesday July 25th, 2018 at 10am PDT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180718005827/en/ Mesh is Tigo's proprietary software that allows each TS4 unit to act as a repeater, extending the

ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 17:21Pressemelding

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li

Xilam: H1 2018 Revenue: +50%18.7.2018 16:00Pressemelding

Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t

Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 12:38Pressemelding

The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign

Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 12:05Pressemelding

Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d